Tizon, Baby Girl I .
HRN: 25-50-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2024
CEFOTAXIME 500MG (VIAL)
07/20/2024
07/27/2024
IV
80mg
Q8h
RDS;PSNB
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes